Skip to content

Eduardo Pondé de Sena

5 papers in the library · 15 citations · publishing 2016-2026

Papers

Sort Most recent Most cited

The Era of Rapid-Acting Antidepressants: Clinical Insights Into Ketamine, Esketamine, and Scopolamine

Discovery medicine September 23, 2026 Jozélio Freire de Carvalho, Eduardo Pondé de Sena

Background: Treatment-resistant depression (TRD) represents a major clinical challenge, being associated with high morbidity, increased suicide risk, and substantial socioeconomic burden. The need for rapidly acting interventions has driven the development of rapid-acting antidepressants (RAADs), such as ketamine, esketamine, and scopolamine. This study aimed to systematically review the...

Ketamine in fibromyalgia: a systematic review.

Advances in rheumatology (London, England) July 29, 2024 Jozélio Freire de Carvalho, Eduardo Pondé de Sena 8 citations

Fibromyalgia (FM) subjects are treated with antidepressant agents; in most cases, these drugs lose efficacy or have adverse effects. Ketamine is an anesthetic drug used in FM in some studies. This article aims to systematically review the safety and efficacy of ketamine in fibromyalgia (FM) patients. We systematically searched articles on FM and ketamine published at Pubmed from 1966 to 2021....

DOI: 10.1186/s42358-024-00393-9 (opens in new tab) Full text (opens in new tab) Depression Anesthetics Ketamine therapy Chronic pain treatment +3

On the advances in machine learning and complex network measures to an EEG dataset from DMT experiments

Journal of Physics: Complexity January 22, 2024 Caroline L. Alves, Manuel Ciba, Thaise G. L. de O. Toutain et al. 5 citations

There is a growing interest in the medical use of psychedelic substances, as preliminary studies using them for psychiatric disorders have shown positive results. In particular, one of these substances is N, N-dimethyltryptamine (DMT), an agonist serotonergic psychedelic that can induce profound alterations in the state of consciousness. In this work, we use an exploratory tool to reveal...

Application of machine learning and complex network measures to an EEG dataset from DMT experiments

medRxiv June 16, 2022 Caroline L. Alves, Thaise G. L. de O. Toutain, Joel Augusto Moura Porto et al. preprint

There is a growing interest in the medical use of psychedelic substances as preliminary studies using them for psychiatric disorders have shown positive results. In particularly, one of these substances is N,N-dimethyltryptamine (DMT) an agonist serotonergic psychedelic that can induce profound alterations in state of consciousness. In this work, we propose a computational method based on...

Associações entre o uso de cannabis e esquizofrenia: uma revisão da literatura

Revista de Ciências Médicas e Biológicas May 24, 2016 Lucas Rocha de Britto, Arão Nogueira de Araújo, Roberto Paulo Correia de Araújo et al. 2 citations

Objetivo: revisar a literatura sobre a associação entre uso de cannabis e o desenvolvimento de esquizofrenia. Metodologia: revisão sistemática da literatura realizada em bases de dados eletrônicas (PubMed e SciELO), que inclui revisões e estudos observacionais (estudos de coorte e cortes transversais) publicados no período de janeiro de 2000 a novembro de 2015, além de estudos encontrados...